1. Resources
  2. Citations Library

Citation Details

You are viewing citation details. You can save or export citation(s) below, access an article, or start a new search.

1–1 of 1 record found matching your query:
Back to Search
Select All  |  Deselect All

Headers act as filters

      1. Author :
        Farelli, Jeremiah D.; Asrani, Kirtika H.; Isaacs, Cleo; deBear, Joanna S.; Stahley, Mary R.; Shah, Anumeha; Lasaro, Melissa A.; Cheng, Christopher J.; Subramanian, Romesh R.
      2. Title :
      3. Type :
        Journal Article
      4. Year :
      5. Publication :
        Nucleic Acid Therapeutics
      6. Products :
      7. Volume :
      8. Issue :
      9. Page Numbers :
      10. Research Area :
      11. Keywords :
        Operetta CLS high-content analysis system; HCS; high-content
      12. Abstract :
        Messenger RNA (mRNA) is a promising new class of therapeutics that has potential for treatment of diseases in fields such as immunology, oncology, vaccines, and inborn errors of metabolism. mRNA therapy has several advantages over DNA-based gene therapy, including the lack of the need for nuclear import and transcription, as well as limited possibility of genomic integration. One drawback of mRNA therapy, especially in cases such as metabolic disorders where repeated dosing will be necessary, is the relatively short in vivo half-life of mRNA (∼6–12 h). We hypothesize that protein engineering designed to improve translation, yielding longer-lasting protein, or modifications that would increase enzymatic activity would be helpful in alleviating this issue. In this study, we present two examples where sequence engineering improved the expression and duration, as well as enzymatic activity of target proteins in vitro. We then confirmed these findings in wild-type mice. This work shows that rational engineering of proteins can lead to improved therapies in vivo.
      13. URL :
      14. Call Number :
        PKI @ Kathryn.Cook @
      15. Serial :
Back to Search
Select All  |  Deselect All